Cutaneous Lymphoma at Injection Sites: Pathological, Immunophenotypical, and Molecular Characterization in 17 Cats.

Authors:
L Crippa
L Crippa
Università degli Studi di Milano
Italy
C Giudice
C Giudice
Università degli Studi di Milano
Italy

Vet Pathol 2016 07 1;53(4):823-32. Epub 2016 Mar 1.

Department of Pathology, Microbiology and Immunology, School of Veterinary Medicine, Davis, CA, USA.

Feline primary cutaneous lymphomas (FPCLs) account for 0.2% to 3% of all lymphomas in cats and are more frequently dermal nonepitheliotropic small T-cell tumors. Emergence of FPCL seems unrelated to feline leukemia virus (FeLV) serological positivity or to skin inflammation. A total of 17 cutaneous lymphomas with a history of vaccine injection at the site of tumor development were selected from 47 FPCLs. Clinical presentation, histology, immunophenotype, FeLV p27 and gp70 expression, and clonality were assessed. A majority of male (12/17), domestic short-haired (13/17) cats with a mean age of 11.3 years was reported. Postinjection time of development ranged from 15 days to approximately 9 years in 5 cats. At diagnosis, 11 of 17 cats had no evidence of internal disease. Lymphomas developed in interscapular (8/17), thoracic (8/17), and flank (1/17) cutaneous regions; lacked epitheliotropism; and were characterized by necrosis (16/17), angiocentricity (13/17), angioinvasion (9/17), angiodestruction (8/17), and peripheral inflammation composed of lymphoid aggregates (14/17). FeLV gp70 and/or p27 proteins were expressed in 10 of 17 tumors. By means of World Health Organization classification, immunophenotype, and clonality, the lesions were categorized as large B-cell lymphoma (11/17), anaplastic large T-cell lymphoma (3/17), natural killer cell-like (1/17) lymphoma, or peripheral T-cell lymphoma (1/17). Lineage remained uncertain in 1 case. Cutaneous lymphomas at injection sites (CLIS) shared some clinical and pathological features with feline injection site sarcomas and with lymphomas developing in the setting of subacute to chronic inflammation reported in human beings. Persistent inflammation induced by the injection and by reactivation of FeLV expression may have contributed to emergence of CLIS.

Download full-text PDF

Source
http://dx.doi.org/10.1177/0300985815623620DOI Listing
July 2016
7 Reads

Publication Analysis

Top Keywords

cutaneous lymphomas
12
injection site
8
t-cell lymphoma
8
injection sites
8
lymphomas
6
cutaneous
5
cats
5
injection
5
peripheral inflammation
4
8/17 peripheral
4
9/17 angiodestruction
4
16/17 angiocentricity
4
necrosis 16/17
4
characterized necrosis
4
angiocentricity 13/17
4
13/17 angioinvasion
4
inflammation composed
4
angioinvasion 9/17
4
angiodestruction 8/17
4
lymphoid aggregates
4

Similar Publications

Prevalence of feline leukaemia provirus DNA in feline lymphomas.

J Feline Med Surg 2010 Dec 30;12(12):929-35. Epub 2010 Oct 30.

Department of Veterinary Pathology, Freie Universität Berlin, Robert-von-Ostertag-Str 15, 14163 Berlin, Germany.

A significant drop in the prevalence of feline leukaemia virus (FeLV) antigenaemic cats and antigen-associated lymphomas has been observed after the introduction of FeLV vaccination and antigen-testing with removal of persistently antigenaemic cats. However, recent reports have indicated that regressively infected cats may contain FeLV provirus DNA and that lymphoma development may be associated with the presence of provirus alone. In the present study, we investigated the presence of FeLV antigen and provirus DNA in 50 lymphomas by immunohistochemistry and semi-nested polymerase chain reaction, respectively. Read More

View Article
December 2010

Feline upper respiratory tract lymphoma: site, cyto-histology, phenotype, FeLV expression, and prognosis.

Vet Pathol 2015 Mar 5;52(2):250-9. Epub 2014 Jun 5.

DIVET, Facoltà di Medicina Veterinaria, Università degli Studi di Milano, Milano, Italy.

Lymphoma is the most common feline upper respiratory tract (URT) tumor. Primary nasal and nasopharyngeal lymphomas have been evaluated as distinct pathological entities; however, data on their differing clinical behavior are missing. A total of 164 endoscopic- guided URT pinch biopsies were formalin fixed and routinely processed. Read More

View Article
March 2015

T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.

Ophthalmology 1999 Nov;106(11):2109-20

Department of Pathology, University Hospital Benjamin Franklin, Berlin, Germany.

Objective: Lymphomas of the eye and its adnexa are frequently of B lineage. This study aims to characterize the clinical and histopathologic features of the rare non-B-cell non-Hodgkin lymphomas (NHL) of these locations.

Design: Retrospective, noncomparative case series. Read More

View Article
November 1999

Immunohistochemical identification of B and T lymphocytes in formalin-fixed, paraffin-embedded feline lymphosarcomas: relation to feline leukemia virus status, tumor site, and patient age.

Can J Vet Res 1996 Jul;60(3):199-204

Department of Veterinary Pathology, Western College of Veterinary Medicine, Saskatoon, Saskatchewan.

The lymphocyte phenotype of 70 formalin-fixed, paraffin-embedded feline lymphosarcomas (LSAs) was determined immunohistochemically using a T cell polyclonal antibody, and a B cell monoclonal antibody. Forty-seven of 70 (67%) tumors were T cell, 19/70 (27%) were B cell, and 4/70 (6%) did not stain with either marker. Thirty-eight of 70 (54%) tumors were positive for feline leukemia virus (FeLV) antigen by immunohistochemistry (IHC), and 52/70 (74%) tumors were positive for FeLV DNA using the polymerase chain reaction (PCR). Read More

View Article
July 1996